MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Last updated: May 7, 2025
Sponsor: OHSU Knight Cancer Institute
Overall Status: Active - Enrolling

Phase

N/A

Condition

Cancer/tumors

Carcinoma

Treatment

Media Intervention

Survey Administration

Training and Education

Clinical Study ID

NCT04996316
STUDY00022698
NCI-2021-06583
STUDY00022698
R01HS027796
  • Ages 40-74
  • Female
  • Accepts Healthy Volunteers

Study Summary

This study collects information to implement MammoScreen for Breast Cancer Screening and Referrals. MammoScreen is a risk assessment questionnaire that identifies individuals at average and increased risk for breast cancer and guides their screening decisions.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Women between the ages of 40 and 74

  • Enrolled in MyChart

  • Able to read English

Exclusion

Exclusion Criteria:

  • Personal history of breast or ovarian cancer

  • Currently Pregnant

  • Currently in Hospice

Study Design

Total Participants: 1141
Treatment Group(s): 5
Primary Treatment: Media Intervention
Phase:
Study Start date:
September 07, 2022
Estimated Completion Date:
August 31, 2025

Study Description

PRIMARY OBJECTIVES:

I. Uptake of MammoScreen (the proportion of women who enroll and use MammoScreen, also referred to as Reach.

II. Identification of women with above-average risk for breast cancer by MammoScreen integrated with the electronic health record (EHR).

SECONDARY OUTCOMES:

I. Rates of mammography screening referral. II. Screening completed and mammography results stratified by risk category. III. Among those who meet criteria, genetic counseling referral, visit completed and genetic test done.

OUTLINE:

CLINICAL STAFF: During development some clinical team members will participate in usability testing (up to 30 minutes) of the electronic health record interface with MammoScreen. Some participants will undergo training sessions of about 20 minutes, then participate in interviews lasting up to 30 minutes at baseline prior to MammoScreen launch. Clinical staff also participate in interviews up to 30 minutes after MammoScreen launch during years 2-4. Participants complete surveys during the maintenance phase about six months after the last reminders are sent.

PATIENTS: Patients (enrolled from OHSU IMC) participate in interviews lasting up to 1 hour. Patients medical records are reviewed. Patients will be invited via MyChart to use the MammoScreen. Reminders will be sent via MyChart to non-respondents at 2 and 4 weeks. Patients will use MammoScreen one time right after enrollment. Some patients may also participate in interviews up to 1 hour each during years 3-5.

Connect with a study center

  • OHSU Knight Cancer Institute

    Portland, Oregon 97239
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.